Yankees Score with ...
Health Care: Health Services
Abbott Laboratories (ABT: NYSE)
$37.76 0.28 | 0.75%
05/24/13 - 04:04 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 5.96B | 4.73B | 4.63B | 5.75B |
| Operating Gains/Losses | 1.35B | 141.56M | 439.54M | -585.16M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 36.00M | -670.15M | -394.66M | -387.75M |
| (Increase) Decrease in Inventories | -417.05M | -129.62M | 139.86M | 230.56M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -134.21M | 1.79B | 572.53M | -374.72M |
| (Decrease) Increase In Other Current Liabilities | -1.31B | -1.40B | -212.09M | 577.42M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 1.08B | 1.06B | 387.18M | 366.36M |
| Net Cash From Continuing Operations | 9.31B | 8.97B | 8.74B | 7.28B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 9.31B | 8.97B | 8.74B | 7.28B |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.80B | -1.49B | -1.02B | -1.09B |
| Acquisitions | -1.23B | -672.50M | -9.43B | -2.37B |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 2.72M | 1.89B | -1.89B | -6.37M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -6.08B | 260.83M | -12.19B | -3.70B |
| Issuance of Debt | 14.70B | -964.68M | 4.00B | 6.22B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.85B | 968.76M | 328.41M | 508.67M |
| Repayment of Long-Term Debt | -11.07B | -3.01B | -1.67B | -2.48B |
| Repurchase of Capital Stock | -2.36B | -77.01M | -866.82M | -826.34M |
| Payment of Cash Dividends | -3.18B | -2.94B | -2.67B | -2.41B |
| Other Financing Charges, Net | 783.87M | 0.00 | -203.85M | 0.00 |
| Net Cash From Financing Activities | 716.09M | -6.02B | -1.09B | 1.00B |
| Effect of Exchange Rate Changes | 40.14M | -43.00M | -620.89M | 118.85M |
| Net Change in Cash & Cash Equivalents | 3.99B | 3.16B | -5.16B | 4.70B |
Portfolios with ABT
- Portfolio NameUser Type
- UserDC
- UserCapt Jer
- UserBruce Watch List
- UserDividend Stocks
- ContributorStocks With Big Insider Buy...
- Usermiamisui Portfolio 1
- UserSteven O
- UserGlobo Gym Investments
- UserDividend
- UserKarens Portfolio
Latest ABT Headlines from TheStreet
- Abbott Laboratories (ABT): Drugs' Featured Winner Of The Day 04.17.13 | 06:04 pm
- Stocks Tumble as Tech, Bank Earnings, Outlook Disappoint 04.17.13 | 04:04 pm
- Cramer Talks Abbott & Glaxo
04.17.13 | 03:04 pm - 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Stocks to Watch: Yahoo!, Intel, Bank of America 04.17.13 | 05:04 am
- Analysts' Actions: HD MA ABT FIS V 04.12.13 | 09:04 am
- Abbott Stock To Go Ex-dividend Tomorrow (ABT) 04.10.13 | 09:04 am
- Abbott Laboratories Stock Hold Recommendation Reiterated (ABT) 04.08.13 | 10:04 am
- Stocks to Watch: Tesla, Verizon, Apple 04.03.13 | 05:04 am
- Abbott Laboratories (ABT): Today's Highlighted Winner For Health Services 04.02.13 | 05:04 pm
Press Releases for ABT
- Absolute Software Shows Positive Movement In The Visionaries Quadrant Of The Magic Quadrant For Client Management Tools - PR Newswire 04.18.13 | 08:04 am
- Abbott Announces FDA Approval And U.S. Launch Of The TECNIS® Toric Intraocular Lens For Cataract Patients - PR Newswire 04.18.13 | 08:04 am
- Abbott Introduces Next Generation Laboratory Automation Solution To Help Meet Increased Testing Demand - PR Newswire 04.16.13 | 08:04 am
- Absolute Software Launches Earth Day Angels Campaign - PR Newswire 04.16.13 | 07:04 am
- Abbott Initiates Voluntary Recall Of FreeStyle InsuLinx® Blood Glucose Meters In The United States - PR Newswire 04.15.13 | 07:04 am
- Absolute Software Issued Patent For A "Persistent Servicing Agent" - PR Newswire 04.11.13 | 07:04 am
- Abbott's Galectin-3 Test Provides Doctors In Europe With New Tool For Assessing The Prognosis Of Chronic Heart Failure Patients - PR Newswire 04.10.13 | 08:04 am
- Absolute Software Announces Global Partnership With Samsung Electronics To Provide Enterprise Mobility Management And Theft Protection To GALAXY Mobile Devices - PR Newswire 04.03.13 | 07:04 am
- Abbott Hosts Conference Call For First-Quarter Earnings - PR Newswire 04.01.13 | 08:04 am
- FDA Advisory Committee Votes Favorably On Abbott's Minimally Invasive MitraClip® Device For Patients With Significant Mitral Regurgitation Who Are Too High Risk For Surgery - PR Newswire 03.20.13 | 07:03 pm
Partner Headlines for ABT
- Abbott Labs' Q1 Earnings Steady After AbbVie Spinoff - Investor's Business Daily 04.17.13 | 04:04 pm
- UPDATE: Abbott Q1 Earnings Fall 56% - Benzinga 04.17.13 | 09:04 am
- Pre-Market Earnings Report for April 17, 2013 : BAC, ABT, PNC, BK, ASML, MAT, DOV, STJ, DGX, TXT, HBAN, FCFS - NASDAQ 04.16.13 | 08:04 pm
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
- Abbott Laboratories Earnings Preview: Can This Streak Continue? - Wall St. Cheat Sheet 04.14.13 | 09:04 am
- Abbott Laboratories Earnings Preview: Can This Streak Continue? - Wall St. Cheat Sheet 04.14.13 | 09:04 am
- Weekly Preview: Earnings Season Kicks Into High Gear - Benzinga 04.12.13 | 04:04 pm
- Is the New Abbot a Winner? - Wall St. Cheat Sheet 04.02.13 | 10:04 am
- AbbVie Offers Nice Dividend Yield, Stock At New High - Investor's Business Daily 04.01.13 | 05:04 pm
- 'Pay For Delay' Case Could Change Generic Drug Rules - Investor's Business Daily 03.26.13 | 04:03 pm
